At least three Wall Street analysts initiated NIQ Global Intelligence (NYSE:NIQ) with a bullish rating on Monday.

Vistra’s rally reflects investor confidence in its earnings performance, highlighted by a quarterly EPS of $1.01 (+12% YOY), ...

The clinical-stage biotech, closely watched by some because of its investigational weight-loss drug VK2735, saw its share price improve by more than 5% as a result. By contrast, the S&P 500 index ...